Atlas Trials

Romiplostim Plus Dexamethasone vs Dexamethasone in Patients With Newly Diagnosed Primary Immune Thrombocytopenia

Clinical trial NCT05325593 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05325593
Sponsor
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Primary Immune Thrombocytopenia
Start date
2022-12-02
Primary completion
2026-10-24
Enrollment
129

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.